相似文献
1
A clinical study of the efficacy of topical corticosteroids on dry eye.
J Zhejiang Univ Sci B. 2006 Aug;7(8):675-8. doi: 10.1631/jzus.2006.B0675.
2
Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.
Ophthalmology. 2007 Jan;114(1):76-9. doi: 10.1016/j.ophtha.2006.05.077. Epub 2006 Oct 27.
3
Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease.
Cornea. 2006 Jul;25(6):674-8. doi: 10.1097/01.ico.0000208813.17367.0c.
4
Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty: a prospective, randomized, clinical trial.
Ophthalmology. 2012 Apr;119(4):668-73. doi: 10.1016/j.ophtha.2011.10.016. Epub 2012 Jan 20.
5
Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.
Am J Ophthalmol. 2007 Jul;144(1):86-92. doi: 10.1016/j.ajo.2007.03.016. Epub 2007 May 9.
6
Experimental study of an automated system for the delivery of eyedrops using a microinfusion pump.
Am J Ophthalmol. 2005 Mar;139(3):547-9. doi: 10.1016/j.ajo.2004.08.051.
7
Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye.
Jpn J Ophthalmol. 2004 Jul-Aug;48(4):321-7. doi: 10.1007/s10384-004-0085-8.
8
[Comparison of local acetylcysteine and artificial tears in the management of dry eye syndrome].
Acta Med Croatica. 2005;59(4):337-40.
9
Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress: A Randomized Controlled Clinical Trial.
Ophthalmology. 2016 Jan;123(1):141-53. doi: 10.1016/j.ophtha.2015.09.029. Epub 2015 Oct 29.
10
[A 0,05% cyclosporine treatment of the advanced dry eye syndrome].
Klin Oczna. 2005;107(4-6):280-6.
引用本文的文献
1
Response predictors of a topical corticosteroid-based regimen for dry eyes: A real-life study.
Acta Ophthalmol. 2025 Feb;103(1):93-98. doi: 10.1111/aos.16758. Epub 2024 Sep 30.
2
Recent Advances in Nanotechnology for the Treatment of Dry Eye Disease.
Nanomaterials (Basel). 2024 Apr 12;14(8):669. doi: 10.3390/nano14080669.
3
Patient-Reported Dry Eye Treatment and Burden of Care.
Eye Contact Lens. 2024 Jun 1;50(6):259-264. doi: 10.1097/ICL.0000000000001086. Epub 2024 Apr 16.
4
A Preservative-Free Approach - Effects on Dry Eye Signs and Symptoms After Cataract Surgery.
Clin Ophthalmol. 2024 Feb 26;18:591-604. doi: 10.2147/OPTH.S446804. eCollection 2024.
5
Effect of Lutein on Ocular Goblet Cell, IFN-γ, and IL-17 Concentration in Dry Eye-Induced Mice Model.
Cureus. 2023 Jul 17;15(7):e42009. doi: 10.7759/cureus.42009. eCollection 2023 Jul.
6
Efficacy of Topical Hydrocortisone in Combination with Topical Ciclosporin A for the Treatment of Dry Eye Disease in Patients with Sjögren Syndrome.
J Ophthalmol. 2021 Nov 30;2021:7584370. doi: 10.1155/2021/7584370. eCollection 2021.
7
A Novel Multi-Ingredient Supplement Reduces Inflammation of the Eye and Improves Production and Quality of Tears in Humans.
Ophthalmol Ther. 2021 Sep;10(3):581-599. doi: 10.1007/s40123-021-00357-y. Epub 2021 Jun 15.
8
Plasma Pharmacokinetic Parameters of Dexamethasone Following Administration of a Dexamethasone Intracanalicular Insert in Healthy Adults.
Clin Ophthalmol. 2021 May 18;15:2055-2061. doi: 10.2147/OPTH.S307194. eCollection 2021.
9
Impact of corneal refractive surgery on the precorneal tear film.
Indian J Ophthalmol. 2020 Dec;68(12):2804-2812. doi: 10.4103/ijo.IJO_2296_19.
10
A Novel Integrated Active Herbal Formulation Ameliorates Dry Eye Syndrome by Inhibiting Inflammation and Oxidative Stress and Enhancing Glycosylated Phosphoproteins in Rats.
Pharmaceuticals (Basel). 2020 Oct 7;13(10):295. doi: 10.3390/ph13100295.
本文引用的文献
1
Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
Ophthalmology. 2006 Feb;113(2):198-205. doi: 10.1016/j.ophtha.2005.09.033. Epub 2005 Dec 19.
2
Effect of inflammation on lacrimal gland function.
Exp Eye Res. 2006 May;82(5):885-98. doi: 10.1016/j.exer.2005.10.018. Epub 2005 Nov 23.
3
Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.
J Ocul Pharmacol Ther. 2005 Apr;21(2):139-48. doi: 10.1089/jop.2005.21.139.
4
A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.
Am J Ophthalmol. 2004 Sep;138(3):444-57. doi: 10.1016/j.ajo.2004.04.052.
5
Changes in the tear film and ocular surface from dry eye syndrome.
Prog Retin Eye Res. 2004 Jul;23(4):449-74. doi: 10.1016/j.preteyeres.2004.04.003.
6
The role of the lacrimal functional unit in the pathophysiology of dry eye.
Exp Eye Res. 2004 Mar;78(3):409-16. doi: 10.1016/j.exer.2003.09.003.
7
ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
Exp Eye Res. 2004 Apr;78(4):823-35. doi: 10.1016/j.exer.2003.10.024.
8
Antiinflammatory therapy for dry eye.
Am J Ophthalmol. 2004 Feb;137(2):337-42. doi: 10.1016/j.ajo.2003.10.036.
9
The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study.
Am J Ophthalmol. 2003 Oct;136(4):593-602. doi: 10.1016/s0002-9394(03)00326-x.
10
Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application.
J Endotoxin Res. 2002;8(6):403-17. doi: 10.1179/096805102125001000.
Zotero 插件